Pasar al contenido principal

ESTUDIO DE LA DINAMICA DE HETERODIMEROS DE RECEPTORES DE QUIMIOQUINAS EN LA MEMBRANA CELULAR: CONSECUENIAS FUNCIONALES

PID2020-114980RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Growth hormone remodels the 3D-structure of the mitochondria of inflammatory macrophages and promotes metabolic reprogramming

  • Soler Palacios, Blanca
  • Villares, Ricardo
  • Lucas, Pilar
  • Rodríguez-Frade, José Miguel
  • Cayuela, Ana
  • Piccirillo, Jonathan G.
  • Lombardía, Manuel
  • Delgado Gestoso, David
  • Fernández-García, Miguel
  • Risco, Cristina
  • Barbas, Coral
  • Corrales, Fernando J.
  • Sorzano, Carlos Óscar S.
  • Martínez-Martín, Nuria
  • Conesa, José J.
  • Iborra, Francisco J.
  • Mellado, Mario
17 páginas, 5 figuras, 1 tabla., Introduction: Macrophages are a heterogeneous population of innate immune cells that support tissue homeostasis through their involvement in tissue development and repair, and pathogen defense. Emerging data reveal that metabolism may control macrophage polarization and function and, conversely, phenotypic polarization may drive metabolic reprogramming. Methods: Here we use biochemical analysis, correlative cryogenic fluorescence microscopy and cryo-focused ion-beam scanning electron microscopy. Results: We demonstrate that growth hormone (GH) reprograms inflammatory GM-CSF-primed monocyte-derived macrophages (GM-MØ) by functioning as a metabolic modulator. We found that exogenous treatment of GM-MØ with recombinant human GH reduced glycolysis and lactate production to levels similar to those found in anti-inflammatory M-MØ. Moreover, GH treatment of GM-MØ augmented mitochondrial volume and altered mitochondrial dynamics, including the remodeling of the inner membrane to increase the density of cristae. Conclusions: Our data demonstrate that GH likely serves a modulatory role in the metabolism of inflammatory macrophages and suggest that metabolic reprogramming of macrophages should be considered as a new target to intervene in inflammatory diseases., This work was supported in part by grants from the Spanish Ministry of Science and Innovation (PID2020-114980RB-I00) Agencia Estatal de Investigación/Fondo Europeo de Desarrollo Regional (AEI/FEDER), Unión Europea, and by a grant from the Regional Government of Madrid P2022/BMD-7274. AC was supported by an FPI fellowship from the Spanish Ministry of Science and Innovation (PRE2018-086112) through the Severo Ochoa excellence accreditation SEV-2017-0712-18-1., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (SEV-2017-0712-18-1), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

AI is a viable alternative to high throughput screening: a 318-target study

  • Chini, Andrea
  • Santiago, César
  • Rodríguez-Frade, José Miguel
  • Mellado, Mario
  • Solano, Roberto
  • García-Cuesta, Eva María
  • Atomwise AIMS Program
High throughput screening (HTS) is routinely used to identify bioactive small molecules. This requires physical compounds, which limits coverage of accessible chemical space. Computational approaches combined with vast on-demand chemical libraries can access far greater chemical space, provided that the predictive accuracy is sufficient to identify useful molecules. Through the largest and most diverse virtual HTS campaign reported to date, comprising 318 individual projects, we demonstrate that our AtomNet® convolutional neural network successfully finds novel hits across every major therapeutic area and protein class. We address historical limitations of computational screening by demonstrating success for target proteins without known binders, high-quality X-ray crystal structures, or manual cherry-picking of compounds. We show that the molecules selected by the AtomNet® model are novel drug-like scaffolds rather than minor modifications to known bioactive compounds. Our empirical results suggest that computational methods can substantially replace HTS as the first step of small-molecule drug discovery., PID2019-107012RB-100 (MICINN/FEDER) and AEI/10.13039/501100011033, "Severo Ochoa" Programme for Centres of Excellence in R&D (SEV-2017-0712). PID2020-114980RB-I00. PID2019-107012RB-100 (MICINN/FEDER) and AEI/10.13039/501100011033, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain

  • García-Cuesta, Eva M
  • Martinez, Pablo
  • Selvaraju, Karthik
  • Ulltjärn, Gabriel
  • Gómez Pozo, Adrián Miguel
  • D'Agostino, Gianluca
  • Gardeta, Sofia
  • Quijada-Freire, Adriana
  • Blanco Gabella, Patricia
  • Roca, Carlos
  • Hoyo, Daniel Del
  • Jiménez-Saiz, Rodrigo
  • García-Rubia, Alfonso
  • Soler Palacios, Blanca
  • Lucas, Pilar
  • Ayala-Bueno, Rosa
  • Santander Acerete, Noelia
  • Carrasco, Yolanda
  • Oscar Sorzano, Carlos
  • Martinez, Ana
  • Campillo, Nuria E.
  • Jensen, Lasse D
  • Rodríguez-Frade, José Miguel
  • Santiago, César
  • Mellado, Mario
CXCR4 is a ubiquitously expressed chemokine receptor that regulates leukocyte trafficking and arrest in both homeostatic and pathological states. It also participates in organogenesis, HIV-1 infection, and tumor development. Despite the potential therapeutic benefit of CXCR4 antagonists, only one, plerixafor (AMD3100), which blocks the ligand-binding site, has reached the clinic. Recent advances in imaging and biophysical techniques have provided a richer understanding of the membrane organization and dynamics of this receptor. Activation of CXCR4 by CXCL12 reduces the number of CXCR4 monomers/dimers at the cell membrane and increases the formation of large nanoclusters, which are largely immobile and are required for correct cell orientation to chemoattractant gradients. Mechanistically, CXCR4 activation involves a structural motif defined by residues in TMV and TMVI. Using this structural motif as a template, we performed in silico molecular modeling followed by in vitro screening of a small compound library to identify negative allosteric modulators of CXCR4 that do not affect CXCL12 binding. We identified AGR1.137, a small molecule that abolishes CXCL12-mediated receptor nanoclustering and dynamics and blocks the ability of cells to sense CXCL12 gradients both in vitro and in vivo while preserving ligand binding and receptor internalization., This work was supported by grants from the Spanish Ministry of Science and Innovation (PID2020-114980RB-­I00) Agencia Estatal de Investigación/Fondo Europeo de Desarrollo Regional (AEI/FEDER), Unión Europea, and by a grant from the Regional Government of Madrid P2022/BMD-­ 7274. CS is supported by MCIN /AEI /10.13039/501100011033/FEDER, UE (PID2022-­ 140651NB-­ I00). NEC is supported by a grant of the Spanish Ministry of Economy, Industry and Competitivity (RTI2018-096100B-­100). RJS is supported by FSE/FEDER through the Instituto de Salud Carlos III (ISCIII; CP20/00043). EG-­ C was supported by the program Apoyos Centros de Excelencia S.O. of the Spanish Ministry of Science and Innovation (SEV-­ 2017-­ 0712). PM and SG are included in the doctoral program of the Department of Molecular Biosciences, Universidad Autónoma de Madrid, and are supported by the Fondo de Personal Investigador (FPI) program of the Spanish Ministry for Science and Innovation (BES2015-­ 071302 and PRE2018-­ 083201 respectively). RA-­ B is supported by the Garantía Juvenil program of the Regional Government of Madrid, Spain (CAM20_CNB_AI_07). We also acknowledge the technical help of the Advance Light Microscopy Unit at the CNB/CSIC. Compounds AGR1.31, AGR1.35 and AGR1.37 are included in the patent PCT/ES2022/070379., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The complex nature of CXCR4 mutations in WHIM syndrome

  • Rodríguez-Frade, José Miguel
  • González-Granado, Luis Ignacio
  • Santiago, César A
  • Mellado, Mario
Heterozygous autosomal dominant mutations in the CXCR4 gene cause WHIM syndrome, a severe combined immunodeficiency disorder. The mutations primarily affect the C-terminal region of the CXCR4 chemokine receptor, specifically several potential phosphorylation sites critical for agonist (CXCL12)-mediated receptor internalization and desensitization. Mutant receptors have a prolonged residence time on the cell surface, leading to hyperactive signaling that is responsible for some of the symptoms of WHIM syndrome. Recent studies have shown that the situation is more complex than originally thought, as mutant WHIM receptors and CXCR4 exhibit different dynamics at the cell membrane, which also influences their respective cellular functions. This review examines the functional mechanisms of CXCR4 and the impact of WHIM mutations in both physiological and pathological conditions., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants from the Spanish Ministry of Science and Innovation (PID2020-114980RB-I00 supported by MCIN/AEI/ 10.13039/501100011033/FEDER, UE) to MM and (PID2022-140651NB-I00 supported by MCIN/AEI/10.13039/501100011033/ FEDER, UE) to CS and from the Biomedicine Program of the Regional Government of Comunidad de Madrid, Spain (S2022/BMD-7274 RETAR-A-COVID-CM) to MM., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dinámica de los receptores de quimioquinas en la membrana celular

  • Mellado, Mario
Discurso de ingreso como Académico Correspondiente de la RANF, Las quimioquinas son citoquinas quimiotácticas que controlan los patrones migratorios y el posicionamiento de muchas células, entre ellas de las inmunitarias. Aunque inicialmente se consideró que las quimioquinas eran importantes mediadores de la inflamación aguda, ahora sabemos que este complejo sistema de ligandos y receptores es fundamental para la generación de respuestas inmunitarias adaptativas primarias y secundarias, tanto celulares como humorales. Además, desencadenan también otras respuestas biológicas que van desde la polarización celular o el movimiento, a la prevención de la infección por VIH- 1. La activación celular mediada por quimioquinas se creía debida a la unión de una quimioquina monomérica a su receptor monomérico. Sin embargo, la biología de estos mediadores es más compleja de lo inicialmente previsto, ya que varios estudios indican que las quimioquinas dimerizan. El uso de nuevas técnicas de imagen óptica avanzada ha permitido observar que también los receptores forman dímeros, homo y heterodímeros, e incluso oligómeros de orden superior en la superficie celular. Son estructuras/conformaciones muy dinámicas y plásticas, influenciadas por la presencia de los ligandos, la coexpresión de otros receptores y proteínas en la membrana celular, la composición lipídica de la misma o del entorno donde la célula realizar su función., Este trabajo ha sido financiado por el Ministerio de Ciencia, Innovación y Universidades (PID2020-114980RB-I00 apoyado por MCIN/AEI/10.13039/501100011033/FEDER, UE) y por el Programa de Biomedicina de la Comunidad de Madrid, España (S2022/BMD-7274 RETAR-A-COVID-CM)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients

  • García-Cuesta, Eva M.
  • Rodríguez-Frade, José Miguel
  • Gardeta, Sofía R.
  • D'Agostino, Gianluca
  • Arranz-Martínez, Pablo
  • Soler Palacios, Blanca
  • Cascio, Graciela
  • Wolf, Tobias
  • Mateos, Nicolas
  • Ayala-Bueno, Rosa
  • Santiago, César A.
  • Lucas, Pilar
  • Llorente, Lucia
  • Allende, Luis M.
  • González-Granado, Luis Ignacio
  • Martín-Cófreces, Noa
  • Roda-Navarro, Pedro
  • Sallusto, Federica
  • Sánchez-Madrid, Francisco
  • García-Parajo, María F.
  • Martínez-Muñoz, Laura
  • Mellado, Mario
Chemokine receptor nanoscale organization at the cell membrane is orchestrated by the actin cytoskeleton and influences cell responses. Using single-particle tracking analysis we show that CXCR4R334X, a truncated mutant chemokine receptor linked to WHIM syndrome (warts, hypogammaglobulinemia, infections, myelokathexis), fails to nanoclusterize after CXCL12 stimulation, and alters the lateral mobility and spatial organization of CXCR4 when coexpressed. These findings correlate with multiple phalloidin-positive protrusions in cells expressing CXCR4R334X, and their inability to correctly sense chemokine gradients. The underlying mechanisms involve inappropriate actin cytoskeleton remodeling due to the inadequate β-arrestin1 activation by CXCR4R334X, which disrupts the equilibrium between activated and deactivated cofilin. Overall, we provide insights into the molecular mechanisms governing CXCR4 nanoclustering, signaling and cell function, and highlight the essential scaffold role of β-arrestin1 to support CXCL12-mediated actin reorganization and receptor clustering. These defects associated with CXCR4R334X expression might contribute to the severe immunological symptoms associated with WHIM syndrome., This work was supported by grants from the Spanish Ministry of Science and Innovation (SAF 2017-82940-R and PID2020-114980RB-I00) and the Redes Temáticas de Investigación Cooperativa en Salud Program (RD12/0009/009; Red de inflamación y Enfermedades Reumáticas [RIER]). L.I.G.-G. is supported by a grant of Fondo de Investigaciones Sanitarias PI21/01642; F.S. and the Institute for Research in Biomedicine are supported by the Helmut Horten Foundation; L.M.-M. is supported by the JIN program from the Spanish Ministry of Science and Innovation (RT12018-101789-J-100). N.M. and M.F.G.-P. acknowledge funding from the European Union H2020 under the Marie Sklodowska-Curie Grant 754558-PREBIST (to N.M.) and European Research Council Grant 788546-NANO-MEMEC (to M.F.G.-P.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cholesterol oxidase treatment impairs CXCR4-mediated T cell migration

  • Gardeta, Sofía R
  • García-Cuesta, Eva M
  • Palacios, Blanca Soler
  • Bueno, Rosa Ayala
  • Quijada-Freire, Adriana
  • Acerete, Noelia Santander
  • Rodríguez-Frade, José Miguel
  • Mellado, Mario
Cholesterol, a key component of mammalian cell membranes, modulates the properties of the lipid bilayer and influences the conformational states of membrane receptors, including G protein-coupled receptors (GPCRs). These effects are mediated through direct interactions with specific residues within the transmembrane regions and modulation of the surrounding lipid bilayer. Chemokine receptors, a GPCR sub-family, adopt distinct conformations associated with specific cell functions. For example, CXCL12 triggers receptor clustering, essential for directional cell migration. However, the precise mechanisms by which cholesterol controls the spatial organization of these receptors remain unclear. This study investigated the role of cholesterol in modulating the chemokine receptor CXCR4., This work was supported by grants from the Spanish Ministry of Science, Innovation and Universities (PID2020-114980RB-I00; PDI2023-146301OB-I00) Agencia Estatal de Investigación/Fondo Europeo de Desarrollo Regional (AEI/FEDER), Unión Europea and the Regional Government of Madrid (CAM P2022zBMD-7274). SRG, AQ-F and NS-A are included in the doctoral program of the Department of Molecular Biosciences, Universidad Autónoma de Madrid, E-28049, Madrid, Spain. SRG, AQ-F and NS-A are supported by grants of the Spanish Ministry of Science and Innovation (FPI program, PRE2018-083201, PRE2019-087966 and PRE2021-098903 respectively). EMG-C was supported by the program Apoyos Centros de Excelencia S.O. of the Spanish Ministry of Science and Innovation (SEV-2017-0712), and BS was supported by the Regional Government of Madrid (CAM P2022/BMD-7274)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

HIV-1 envelope glycoprotein modulates CXCR4 clustering and dynamics on the T cell membrane

  • Quijada-Freire, Adriana
  • Santiago, César
  • García-Cuesta, Eva María
  • Soler Palacios, Blanca
  • Gardeta, Sofia R.
  • San Sebastian, Enara
  • Armendariz- Burgoa, Eva
  • Puertas, Maria Carmen
  • Villares, Ricardo
  • Garaigorta, Urtzi
  • Luis Ignacio González- Granado
  • Rodríguez-Frade, José Miguel
  • Jakub Chojnacki
  • Javier Martinez-Picado
  • Mellado, Mario
HIV-1 entry into susceptible cells requires the dynamic interaction of its envelope (Env) glycoprotein with the host cell receptor CD4 and a co-receptor, either CCR5 or CXCR4. While the core molecular mechanisms driving Env-receptor interactions and subsequent membrane fusion are well characterized, the precise nanoscale spatial reorganization of these co-receptors at the viral binding site remains poorly defined. In this study, we employed single-particle tracking total internal reflection fluorescence (SPT-TIRF) microscopy to quantitatively analyze nanoscale organizational changes of CXCR4 on the surface of human CD4+ T cells following binding by X4-tropic HIV-1. Our data reveal that both recombinant X4-gp120 and virus-like particles expressing physiological levels of X4 Env proteins (gp120 and gp41) promote CXCR4 clustering, a phenomenon linked to cell infection. Furthermore, these ligands induced oligomerization of CXCR4R334X, a naturally occurring mutant associated with WHIM syndrome that supports HIV-1 infection, but fails to oligomerize in response to CXCL12. Our findings establish a link between CXCR4 clustering and HIV-1 infection, enhancing our understanding of the initial events in viral attachment and entry. These results further suggest that HIV-1 depends on a specific spatial arrangement of co-receptors, distinct from that induced by their natural chemokine ligands, highlighting the critical role of cell-surface receptor spatial organization in dictating cellular function., Spanish National Plan for Scientific and Technical Research and Innovation (PID2020-114980RB-I00) Fundación para el Conocimiento Madri+d (CAM20_CNB_AI_07) Federación Española de Enfermedades Raras (FIS PI21/01642) Spanish National Plan for Scientific and Technical Research and Innovation (PID2023-146301OB-I00) Spanish National Plan for Scientific and Technical Research and Innovation (PID2022-140651NB-I00) Spanish National Plan for Scientific and Technical Research and Innovation (PID2022-139271OB-I00) Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas (CB21/13/00063) Centro Nacional de Biotecnología (SEV-2017-0712) Spanish National Plan for Scientific and Technical Research and Innovation (PRE2018-083201) Spanish National Plan for Scientific and Technical Research and Innovation (PRE2019-087966) Spanish National Plan for Scientific and Technical Research and Innovation (PRE2022-000847), Peer reviewed, Modelo experimental alternativo-NAM, in vitro - Tipos celulares